Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation

被引:0
作者
Wils, Leon J. [1 ,2 ,3 ,4 ,5 ]
Buijze, Marijke [2 ,5 ]
Stigter-van Walsum, Marijke [2 ,5 ]
Brink, Arjen [2 ,5 ]
van Kempen, Britt E. [2 ,5 ]
Peferoen, Laura [3 ]
Brouns, Elisabeth R. [1 ,4 ]
de Visscher, Jan G. A. M. [1 ,4 ]
van der Meij, Erik H. [1 ,4 ]
Bloemena, Elisabeth [1 ,2 ,4 ,5 ]
Poell, Jos B. [2 ,5 ]
Brakenhoff, Ruud H. [2 ,5 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam UMC Locat, Oral & Maxillofacial Surg & Oral Pathol, NL-1081 HV Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam UMC Locat, Otolaryngol & Head & Neck Surg, NL-1081 HV Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Amsterdam UMC Locat, Pathol, NL-1081 HV Amsterdam, Netherlands
[4] Acad Ctr Dent Amsterdam ACTA, NL-1081 LA Amsterdam, Netherlands
[5] Canc Ctr Amsterdam CCA, Canc Biol & Immunol, NL-1081 HV Amsterdam, Netherlands
关键词
oral diseases; oral leukoplakia; oral squamous cell carcinoma; malignant transformation; CRISPR/Cas9; cell culture models; small molecule inhibitors; genetic engineering; GENETICALLY ALTERED FIELDS; KINASE; INHIBITOR; NECK-CANCER; DOUBLE-BLIND; CELL-LINES; TERT GENE; PHASE-I; HEAD; LEUKOPLAKIA; MUTATIONS;
D O I
10.3390/cells13080710
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Precancerous cells in the oral cavity may appear as oral potentially malignant disorders, but they may also present as dysplasia without visual manifestation in tumor-adjacent tissue. As it is currently not possible to prevent the malignant transformation of these oral precancers, new treatments are urgently awaited. Here, we generated precancer culture models using a previously established method for the generation of oral keratinocyte cultures and incorporated CRISPR/Cas9 editing. The generated cell lines were used to investigate the efficacy of a set of small molecule inhibitors. Tumor-adjacent mucosa and oral leukoplakia biopsies were cultured and genetically characterized. Mutations were introduced in CDKN2A and TP53 using CRISPR/Cas9 and combined with the ectopic activation of telomerase to generate cell lines with prolonged proliferation. The method was tested in normal oral keratinocytes and tumor-adjacent biopsies and subsequently applied to a large set of oral leukoplakia biopsies. Finally, a subset of the immortalized cell lines was used to assess the efficacy of a set of small molecule inhibitors. Culturing and genomic engineering was highly efficient for normal and tumor-adjacent oral keratinocytes, but success rates in oral leukoplakia were remarkably low. Knock-out of CDKN2A in combination with either the activation of telomerase or knock-out of TP53 seemed a prerequisite for immortalization. Prolonged culturing was accompanied by additional genetic aberrations in these cultures. The generated cell lines were more sensitive than normal keratinocytes to small molecule inhibitors of previously identified targets. In conclusion, while very effective for normal keratinocytes and tumor-adjacent biopsies, the success rate of oral leukoplakia cell culturing methods was very low. Genomic engineering enabled the prolonged culturing of OL-derived keratinocytes but was associated with acquired genetic changes. Further studies are required to assess to what extent the immortalized cultures faithfully represent characteristics of the cells in vivo.
引用
收藏
页数:25
相关论文
共 96 条
[91]   Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation [J].
Wils, Leon J. ;
Poell, Jos B. ;
Brink, Arjen ;
Evren, Ilkay ;
Brouns, Elisabeth R. ;
de Visscher, Jan G. A. M. ;
Bloemena, Elisabeth ;
Brakenhoff, Ruud H. .
CLINICAL CANCER RESEARCH, 2023, 29 (03) :602-613
[92]   A Pilot Surrogate Endpoint Biomarker Study of Celecoxib in Oral Premalignant Lesions [J].
Wirth, Lori J. ;
Krane, Jeffrey F. ;
Li, Yi ;
Othus, Megan ;
Moran, Amy E. ;
Dorfman, David M. ;
Norris, Charles M., Jr. ;
Goguen, Laura ;
Posner, Marshall R. ;
Haddad, Robert I. ;
Bertagnolli, Monica M. .
CANCER PREVENTION RESEARCH, 2008, 1 (05) :339-348
[93]   Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: Implications for patients with oral precancerous lesions [J].
Yagyuu, Takahiro ;
Hatakeyama, Kinta ;
Imada, Mitsuhiko ;
Kurihara, Miyako ;
Matsusue, Yumiko ;
Yamamoto, Kazuhiko ;
Obayashi, Chiho ;
Kirita, Tadaaki .
ORAL ONCOLOGY, 2017, 68 :36-43
[94]   A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma [J].
Yang, Eddy S. ;
Deutsch, Eric ;
Mehmet, Altan ;
Fayette, Jerome ;
Tao, Yungan ;
Nabell, Lisle ;
Spencer, Sharon A. ;
Wang, Xuejing A. ;
Spoljoric, Elizabeth A. ;
Zhang, Wei ;
Hynes, Scott M. ;
Decker, Rodney L. ;
Lin, Aimee K. Bence ;
William, William N., Jr. .
RADIOTHERAPY AND ONCOLOGY, 2021, 157 :203-209
[95]   Promoter region mutations of the telomerase reverse transcriptase (TERT) gene in head and neck squamous cell carcinoma [J].
Yilmaz, Ismail ;
Erkul, Bulent Evren ;
Sari, Sule Ozturk ;
Issin, Gizem ;
Tural, Ersin ;
Terzi, Neslihan Kaya Terzi ;
Karatay, Huseyin ;
Celik, Mehmet ;
Ulusan, Murat ;
Bilgic, Bilge .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2020, 130 (01) :63-70
[96]   3D Co-culture of Cancer-Associated Fibroblast with Oral Cancer Organoids [J].
Zhao, H. ;
Jiang, E. ;
Shang, Z. .
JOURNAL OF DENTAL RESEARCH, 2021, 100 (02) :201-208